Development of inhalation-enhanced new drugs and non-clinical CRO services using advanced/animal replacement tests

Representative: Young-Jae Cho / Division of Pulmonary and Critical Care Medicine
Associated Disease: ARDS, respiratory infections (viruses, non-tuberculous mycobacteria), inhalation injury
Requirements: Investment , Business model consult, joint research , M&A
Views: 29

ECG BuddyECG Buddy

Related Sites